
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
[ Tue, May 16th 2023 ]: WOPRAI
Ross Osborn Reiterated (XGN) at Buy and Held Target at $6 on, May 16th, 2023


🞛 This publication is a summary or evaluation of another publication
Ross Osborn of Cantor Fitzgerald, Reiterated "Exagen Inc." (XGN) at Buy and Held Target at $6 on, May 16th, 2023.
Ross has made no other calls on XGN in the last 4 months.
There is 1 other peer that has a rating on XGN. Out of the 1 peers that are also analyzing XGN, 0 agree with Ross's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ross
- Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $5 on, Wednesday, March 22nd, 2023